Trials / Completed
CompletedNCT03968471
Chemotherapy-induced Necrosis in Ewing Sarcoma
Chemotherapy-induced Necrosis in Ewing Sarcoma: Which is the Best Scoring Tool
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 474 (actual)
- Sponsor
- Istituto Ortopedico Rizzoli · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is single institution cases series review of histological and clinical data
Detailed description
Investigators will retrieve from the database of the Rizzoli institute all the cases with a histological diagnosis of Ewing sarcoma from 01 Jan 1982 to 31 Dic 2012
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Scoring tool in Chemotherapy-induced necrosis in Ewing sarcoma | The aim of the present study is to evaluate which is the best scoring tool to determine the histological response to chemotherapy in localized Ewing sarcoma of bone. The study will exam all the different systems to evaluate the histological necrosis after neo-adjuvant chemotherapy in all patients with localized Ewing sarcomas of bone surgically treated between 1982 and 2012. |
Timeline
- Start date
- 2019-05-13
- Primary completion
- 2019-12-31
- Completion
- 2020-01-15
- First posted
- 2019-05-30
- Last updated
- 2020-01-22
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03968471. Inclusion in this directory is not an endorsement.